DGAP-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Preliminary Results
MeVis Medical Solutions AG: Announcement of preliminary results for the financial year 2016/2017

11-Jan-2018 / 19:17 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Bremen, January 11, 2018 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, announces its preliminary results for the financial year 2016/2017 (October 1, 2016 to September 30, 2017):

  • Revenues: EUR 18.5 million (previous forecast: significant increase in revenues to EUR 18.0 million to EUR 18.5 million)
  • EBIT: EUR 8.0 million (previous forecast: significant increase to EUR 6.0 million to EUR 6.5 million)

The annual financial statements of MeVis Medical Solutions AG will be published on January 23, 2018.

 

11-Jan-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet:http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange

 
End of Announcement DGAP News Service

644913  11-Jan-2018 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=644913&application_name=news&site_id=zonebourse